← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exesalibero, Inc.
Morgantown, WV
$1,708,950
Total funding
1
Grants
Funding over time
peak $1.2M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$1,708,950 · 1
By mechanism
R42$1,708,950 · 1
Investigators at Exesalibero, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline$1,103,697
R42 · FY2020 · AR
Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline$394,939
R42 · FY2021 · AR
Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide N-Methyl Dichloropropionaniline$108,153
R42 · FY2020 · AR
Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline$102,161
R42 · FY2019 · AR